美股异动丨工业大麻股盘前再度上涨，特朗普据报最早本周签行政命令放宽大麻类管制

Core Viewpoint - Industrial hemp stocks have seen a pre-market surge, with notable increases in companies such as CbdMD, Canopy Growth, and Tilray Brands, driven by expectations of a forthcoming executive order from President Trump to ease cannabis regulations and recognize its medical use at the federal level [1] Group 1: Market Reactions - CbdMD shares rose nearly 14% in pre-market trading [1] - Canopy Growth shares increased by over 7% [1] - Tilray Brands shares saw an increase of nearly 2% [1] Group 2: Executive Order Expectations - President Trump is expected to sign an executive order as early as this week to relax cannabis classification regulations [1] - The order is anticipated to direct the Drug Enforcement Administration or the Department of Justice to issue final regulations reclassifying cannabis from a Schedule I substance to Schedule III [1] - The executive order may also instruct Congress to pass legislation allowing legal cannabis businesses access to major banking and financial services [1] Group 3: Healthcare Implications - The executive order could direct the Centers for Medicare & Medicaid Services to permit reimbursement for cannabidiol (CBD) products under Medicare [1]